Founded in 1969, PHARMATHEN has become one of the largest, vertically integrated developers of complex drug delivery technologies. With best-in-class research & development capabilities, Pharmathen is working on one of the industry’s most extensive and advanced pipelines consisting of more than 40 products produced in its US FDA and EU-approved manufacturing facilities in Greece. Pharmathen’s highly diversified product portfolio of more than 90 commercialized products is sold to 250 customers and accessed by patients in more than 90 countries worldwide.